INEX Innovate
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
INEX Innovate - overview
Established
2014
Location
Singapore, -, Singapore
Primary Industry
Healthcare
About
Founded in 2019 and based in Singapore, INEX Innovate is the merged entity of Nova Satra Dx Pte. Ltd. and INEX Innovations Exchange Pte Ltd that operates as a femtech company, providing reproductive health solutions for women. The company's products include OvaCis, a point-of-care kit that distinguishes benign from malignant ovarian cysts in minutes, Zena, a blood-based test for the early detection of ovarian cancer, and NovoTectTMBC, an epigenetics-based early detection test for breast cancer.
Current Investors
Genting Berhad, SEEDS Capital
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment
Website
www.inex.sg
Total Amount Raised
Subscriber access only
INEX Innovate - timeline of key events
INEX Innovate - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Announced | Yourgene Health's Taiwanese Genomics Business | - |
Displaying 1 - 1 of 1
INEX Innovate - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.